FindTrial
Sign In

R Low dose oral minoxidil 1.25mg in male androgenetic alopecia

Randomised prospective case control study on Low dose oral minoxidil 1.25mg in male androgenetic alopecia (AGA), and to compare the pre- and post-treatment dermoscopic features in male androgenetic alopecia (AGA).

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/082882
Enrollment
200
Registered
2025-03-20
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L648- Other androgenic alopecia

Interventions

Intervention1: Oral Minoxidil: Oral route, 1.25mg Control Intervention1: Placebo: Oral route, 5mg

Sponsors

Dr Abhijeet Kumar Jha Patna Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 18 to 45 year MAGA patients.

Exclusion criteria

Exclusion criteria: Those with cardiovascular disease and hypersensitivity to minoxidil

Design outcomes

Primary

MeasureTime frame
Change in hair count per cm Change in hair diameterTimepoint: Baseline, 4 weeks, 8 weeks, 12 weeks, 16 weeks, 20 weeks, 24 weeks—

Secondary

MeasureTime frame
Adverse effectsTimepoint: 6 months—

Countries

India

Contacts

Public ContactAbhijeet Kumar Jha

Patna Medical College

drabhijeetjha@gmail.com09631444797

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026